Skip to main content
European Commission logo print header

Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery.

Objectif

Breakthrough gene expression search engine for cost reduction and significantly increased use of open data in drug discovery. We are putting the power of genetic data analytics into the cloud and providing this as an easy to access service to biologists via a search engine. The challenge today is that as the field of sequencing is developing at a rapid pace and the amount of genetic data is exploding, nobody really can analyze all that data and pull it up when needed for making informed decision in the field of drug development and life science research. We are seizing this business opportunity through our competitive edge by creating an easily usable cloud-based gene expression search engine on top of publicly available datasets that have been analyzed and indexed by our advanced algorithms. This allows for providing unexpected discoveries in the field of drug discovery at a significantly reduced rate and insight, which has not been possible before. 

Appel à propositions

H2020-SMEInst-2014-2015

Voir d’autres projets de cet appel

Sous appel

H2020-SMEINST-1-2014

Régime de financement

SME-1 - SME instrument phase 1

Coordinateur

MEDICAL TECHNOLOGY GROUP OU
Contribution nette de l'UE
€ 50 000,00
Adresse
Ravala 8
10143 Tallinn
Estonie

Voir sur la carte

PME

L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.

Oui
Région
Eesti Eesti Põhja-Eesti
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 71 429,00